Characterization of a switchable chimeric antigen receptor platform in a pre-clinical solid tumor model.
Pishali Bejestani E, Cartellieri M, Bergmann R, Ehninger A, Loff S, Kramer M, Spehr J, Dietrich A, Feldmann A, Albert S, Wermke M, Baumann M, Krause M, Bornhäuser M, Ehninger G, Bachmann M, von Bonin M.
Pishali Bejestani E, et al. Among authors: dietrich a.
Oncoimmunology. 2017 Jun 20;6(10):e1342909. doi: 10.1080/2162402X.2017.1342909. eCollection 2017.
Oncoimmunology. 2017.
PMID: 29123951
Free PMC article.